Effect of a cholinomimetric drug (RS 86) in tardive dyskinesia and drug-related parkinsonism.

Autor:	Noring, U., Juul Povlsen, U., Casey, D., Gerlach, J.
Zdroj:	Psychopharmacology; 1984, Vol. 84 Issue 4, p569-571, 3p
Abstrakt:	RS 86, a specific muscarinic agonist, was evaluated in a blind, placebo-controlled, single-dose trial in 10 psychiatric patients with stable tardive dyskinesia (TD). RS 86, 0.5-4 mg orally, produced no significant effects in TD, although 4 mg caused a minimal aggravation in parkinsonism. Side effects of the highest dose (4 mg) included hypersalivation (eight patients), nausea (6), sweating (3), and vomiting (3). It is concluded that treatmetn with RS 86 and probably other cholinomimetics has no or only limited beneficial effect in TD. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink